KEY POINTS:
Biotechnology company Blis Technologies has sealed a more expansive distribution and marketing deal with Auckland pharmacy distributor Pharmabroker Sales Ltd.
Blis says the arrangement will maximise the potential of its probiotics products, making Pharmabroker responsible for the sales and marketing of all Blis products in New Zealand.
Currently Blis manufactures an oral treatment to counter upper respiratory infection and chronic bad breath.
It recently entered into research and development contract with nutrition giant, Nestle.
- NZPA
